Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 13

Could Short Chains of Amino Acids Revolutionize Anti-aging? We explore the exciting potential of peptide therapy to address key hallmarks of aging, including biological age and telomere length. This video delves into the science behind peptides and examines early clinical findings that suggest significant possibilities for age reversal.

What you’ll learn:
• Key peptides being studied for anti-aging (Epitalon, GHK-Cu, etc.).
• A look at clinical studies and patient data.
• The future of peptide therapy in longevity research.

Credits to : glycanage, dr. luis martinez of clinical peptide society

Please note that the links below are affiliate links, so we receive a small commission when you purchase a product through the links. Thank you for your support!
=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=*=
☑ ProHealth, RENUE, DoNotAge, StemRegen, N1O1, NOVOS ☑ Coupon CODE: REVERSE

Activate Your Stem Cells Naturally — STEMREGEN 15% OFF https://tinyurl.com/StemRelease.

📒Dr Bryan Nitric Oxide Supplement 📒20% OFF Code LAFIRE

Continue reading “30 Years Younger & Telomere Extension? Could Short Chains of Amino Acids Revolutionize Anti-aging?” | >

When your social media account starts spewing out nonsensical or threatening status updates, it’s safe to assume that it has been hacked and must be shut down.

The cells in our body also update their “status” by presenting to their environment small proteins that are constantly being produced inside the cell. Our monitors these statuses and destroys cells that produce unusual proteins. A classic example of this is when a cell is infected by a virus and presents parts of the viral proteins on its surface, which allows the immune system to recognize them and destroy the cell.

In contrast, cancer cells often evade detection by displaying very few suspicious proteins that the immune system can identify and target. A new approach to cancer treatment, developed by researchers from Prof. Yardena Samuels’s lab at the Weizmann Institute of Science, increases the number of the immune system’s targets by disrupting production in .

Read more | >

(https://twitter.com/neuralink/status/1907493477086117955)

We’ve detected that JavaScript is disabled in this browser. Please enable JavaScript or switch to a supported browser to continue using x.com. You can see a list of supported browsers in our Help Center.

Help Center

Terms of Service Privacy Policy Cookie Policy Imprint Ads info © 2025 X Corp.

Read more | >

At the viral chatter stage of an outbreak, pathogens are just starting to infect people in sporadic bursts. It’s a sign that a pandemic may be on the horizon.

Read more | >

A team led by Professor Kazuhiro Maeshima of the National Institute of Genetics (ROIS) and SOKENDAI in Japan has developed a method to visualize different types of chromatin and reveal their distinct physical properties. They published their approach and findings on March 28 in Science Advances.

Inside every human cell, 2 meters of DNA must be tightly packed into a tiny nucleus. This DNA is wrapped around proteins to form chromatin, which exists in two main forms: euchromatin, where genes are active, and heterochromatin, where is suppressed.

“How these two types of chromatin are organized and behave inside living cells is still not well understood,” says Katsuhiko Minami, the first author of this study. “Until now, we lacked a way to specifically label euchromatin and heterochromatin in .”

Read more | >

Researchers at the University of California, Los Angeles (UCLA) are developing a gene-editing therapy — designed to be delivered as a one-time inhalable treatment — that aims to correct the underlying mutations that cause cystic fibrosis (CF).

The team is using tiny fat-based particles to deliver the gene-editing machinery to lung stem cells, where, they believe, gene correction could be permanent. The treatment, according to a university news story, could offer hope to people with the genetic disease who do not benefit from current therapies.

CF is caused by mutations in the CFTR gene, which normally produces a protein of the same name. This CFTR protein helps regulate the flow of water and salt molecules in and out of certain cells, which is essential for the production of mucus. In CF, missing or dysfunctional CFTR instead results in the accumulation of thick and sticky mucus in several organs, particularly the lungs. This, in turn, leads to symptoms like shortness of breath, cough, and frequent lung infections.

Read more | >

Researchers at the University of Missouri, in collaboration with Novartis Pharmaceuticals, have developed a groundbreaking and environmentally friendly electrochemistry technique. This new method uses engineered “soapy” water, micelles made from natural amino acids and coconut oil, combined with electricity to drive chemical reactions in a safer, more sustainable way.

Unlike traditional electrochemical processes that rely on toxic solvents and electrolytes, this approach offers a non-toxic alternative. Led by Associate Professor Sachin Handa and graduate student Karanjeet Kaur, the team’s innovation could significantly reduce the cost of pharmaceutical manufacturing and advance clean energy technologies. It also shows promise in tackling environmental challenges, such as removing persistent “forever chemicals” like per-and polyfluoroalkyl substances (PFAS) from water.

These ball-shaped structures have two sides: one that mixes with water and the other that repels it. Their unique design allowed researchers to make electrochemical reactions more efficient by combining the traditional roles of solvents, electrolytes, and reaction boosters into one simple tool. Bonus: The reactions are highly efficient and selective.

Read more | >